First Cat-Specific Blood Pressure Drug Approved — and the FDA File Shows Why Catching It Late Costs Vision
On April 29, 2026 the FDA approved AMODIP (amlodipine besylate chewable tablets, Ceva) — the first cat-specific drug for systemic hypertension in cats. In the field study systolic pressure fell 28.2 mmHg on average by Day 28. But the same FDA file notes that cats whose vision was already severely lost at treatment start were less likely to regain it even after the retina reattached. Feline hypertension travels with kidney disease and is invisible at home. What to do now.

What Was Approved

midArticleCta.byCategory.news.title
midArticleCta.byCategory.news.description
Över 380 000 kattägare i 50 länder litar på CatsMe
Feline Hypertension Travels With Kidney Disease — and Shows You Nothing at Home
The Real Story Is One Sentence in the FDA File
Cats that had severe fundic lesions and severely decreased or absent vision at the start of treatment were less likely to regain visual function, despite retinal reattachment and improvement in retinal hemorrhages.
What To Do Now: Start by Asking for the Measurement
Turn Invisible Change Into a Record — CatsMe
Kan du svara på "när började det här?"
När veterinären frågar, stå inte svarslös. CatsMe registrerar automatiskt dagliga hälsopoäng som du kan dela med en knapptryckning.
FAQ

Var redo att agera i samma ögonblick du känner att något inte stämmer
En bild räcker: AI:n läser av smärta och hälsa i kattens ansiktsuttryck. Kontrollera i stunden du blir orolig och dela loggen med veterinären.